Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsutomu Inoue

Showing results (61-70 of 140) with videos related to

Pageof 14
Sort By:
CEN Case Reports|March 2, 2023
A case of hemophagocytic lymphohistiocytosis in a hemodialysis patient with coronavirus disease 2019Satoru Kaneko, Tsutomu Inoue, Norihito Tarumoto, et al.
Plos One|April 24, 2026
Reappraisal of profibrotic phenotype and cell-cycle state of renal tubular epithelium after ischemia-reperfusion injuryDaichi Fukaya, Wakako Kosakai, Tetsuya Sato, et al.
American Journal of Physiology. Renal Physiology|May 29, 2015
Antialbuminuric actions of calcilytics in the remnant kidneyTsuneo Takenaka, Tsutomu Inoue, Takashi Miyazaki, et al.
The Journal of Organic Chemistry|June 14, 1996
A Synthesis of D,L-N,N-Dimethylcycloisodityrosines: A Comment on the Stereochemistry of Previously Reported Intermediates Related to the Synthesis of RA-VII and DeoxybouvardinTsutomu Inoue, Tomomitsu Sasaki, Hiroaki Takayanagi, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 12, 2011
Testing a single monthly dose of darbepoetin alpha to maintain hemoglobin levels in continuous ambulatory peritoneal dialysis patientsHiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 12, 2011
Does cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis?Hiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitorsTakahiro Sato, Naoki Ashizawa, Takashi Iwanaga, et al.
Organic Letters|February 1, 2007
General asymmetric hydrogenation of alpha-branched aromatic ketones catalyzed by TolBINAP/DMAPEN-ruthenium(II) complexNoriyoshi Arai, Hirohito Ooka, Keita Azuma, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]Takahiro Sato, Naoki Ashizawa, Koji Matsumoto, et al.
Chemistry, an Asian Journal|May 8, 2008
Enantiomer-selective carbamoylation of racemic alpha-hydroxy gamma-lactones with chiral Cu(II) Catalysts: an example of a highly active Lewis acid catalyzed reactionNobuhito Kurono, Tadahiro Kondo, Masanori Wakabayashi, et al.
Pageof 14

Showing results (61-70 of 140) with videos related to

Sort By:
Pageof 14
CEN Case Reports|March 2, 2023
A case of hemophagocytic lymphohistiocytosis in a hemodialysis patient with coronavirus disease 2019Satoru Kaneko, Tsutomu Inoue, Norihito Tarumoto, et al.
Plos One|April 24, 2026
Reappraisal of profibrotic phenotype and cell-cycle state of renal tubular epithelium after ischemia-reperfusion injuryDaichi Fukaya, Wakako Kosakai, Tetsuya Sato, et al.
American Journal of Physiology. Renal Physiology|May 29, 2015
Antialbuminuric actions of calcilytics in the remnant kidneyTsuneo Takenaka, Tsutomu Inoue, Takashi Miyazaki, et al.
The Journal of Organic Chemistry|June 14, 1996
A Synthesis of D,L-N,N-Dimethylcycloisodityrosines: A Comment on the Stereochemistry of Previously Reported Intermediates Related to the Synthesis of RA-VII and DeoxybouvardinTsutomu Inoue, Tomomitsu Sasaki, Hiroaki Takayanagi, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 12, 2011
Testing a single monthly dose of darbepoetin alpha to maintain hemoglobin levels in continuous ambulatory peritoneal dialysis patientsHiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|November 12, 2011
Does cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis?Hiromichi Suzuki, Tsutomu Inoue, Yusuke Watanabe, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2008
Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1,2,4-triazole derivatives as xanthine oxidoreductase inhibitorsTakahiro Sato, Naoki Ashizawa, Takashi Iwanaga, et al.
Organic Letters|February 1, 2007
General asymmetric hydrogenation of alpha-branched aromatic ketones catalyzed by TolBINAP/DMAPEN-ruthenium(II) complexNoriyoshi Arai, Hirohito Ooka, Keita Azuma, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]Takahiro Sato, Naoki Ashizawa, Koji Matsumoto, et al.
Chemistry, an Asian Journal|May 8, 2008
Enantiomer-selective carbamoylation of racemic alpha-hydroxy gamma-lactones with chiral Cu(II) Catalysts: an example of a highly active Lewis acid catalyzed reactionNobuhito Kurono, Tadahiro Kondo, Masanori Wakabayashi, et al.
Pageof 14